Delta-like Ligand 1 For Diagnosing Severe Infections

Abstract

The invention refers to a method for in vitro diagnosis of a severe infection comprising determining delta-like ligand 1 protein or a nucleotide sequence coding for delta-like ligand 1 protein in a biological sample wherein an elevated level of expression of delta- like ligand 1 protein or a nucleotide sequence coding for delta-like ligand 1 protein is indicative of a severe infection; and the use of delta-like ligand 1 protein as a biomarker for in vitro diagnosis of a severe infection such as sepsis.


Claims
Download PDF
Document Preview
Document History
  • Publication: May 2, 2019
  • Application: Oct 25, 2018
    WO EP 2018079273 W
  • Priority: Oct 25, 2017
    EP EP 17198330 A

Download Citation


Sign in to the Lens

Feedback